Comprehensive Pan-Cancer Analysis of Connexin 43 as a Potential Biomarker and Therapeutic Target in Human Kidney Renal Clear Cell Carcinoma (KIRC)
Huzi Xu(Tongji Hospital), Ying Yao(Peking University), Zhihui Lu(Fudan University), Xiuru Wang(Jilin University), Rui Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Fan Zhu(Wuhan University), Juan Yang(Tongji Hospital), Meng Wang(Harbin Medical University), Han Zhu(Shanghai Medical College of Fudan University), Shuiming Guo(Tongji Hospital), Zheng Chao(Tongji Hospital), Fengming Zhu(Tongji Hospital), Chujin Cao(Tongji Hospital)
Cited by 3
Related Papers
LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge
|Cell Death and Disease|2018|160
METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1
|Cell Death and Disease|2021|115
Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation
|Hepatology|2012|85
3d–4f Metal–Organic Framework with Dual Luminescent Centers That Efficiently Discriminates the Isomer and Homologues of Small Organic Molecules
|Inorganic Chemistry|2016|81
Genetically programmable cell membrane-camouflaged nanoparticles for targeted combination therapy of colorectal cancer
|Signal Transduction and Targeted Therapy|2024|81